Laboratory Medicine in Hematology
A special issue of LabMed (ISSN 2813-9038).
Deadline for manuscript submissions: 30 November 2025 | Viewed by 23
Special Issue Editor
Special Issue Information
Dear Colleagues,
Laboratory medicine is crucial for diagnosing and monitoring hematological disorders and guiding therapeutic decisions. LabMed is pleased to announce the launch of this Special Issue, which is dedicated to the study of hematology. We welcome the submission of papers broadly related to laboratory investigations in this area, including coagulation, disorders of platelets, red cells, and leukocytes, and hematological malignancies. The development of innovative molecular tests and laboratory technologies helps provide greater insights into clinical disorders, and the publication of new findings can facilitate the implementation of these tools. Additionally, numerous therapeutic advances, such as new anticoagulants, therapeutic monoclonal antibodies, and chimeric antigen receptor T-cell therapies (CAR-T), are enhancing the efficacy of laboratory evaluations.
LabMed is a new open access journal that rapidly distributes research that can be accessed without a subscription. The journal’s peer review process is fast, and editing support is available.
Dr. Glen L. Hortin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. LabMed is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematology
- coagulation
- anemia evaluation
- platelet disorders
- evaluation of hematological malignancies
- laboratory evaluation of thrombosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
